David R. Lally, MD, FASRS is the Director of the Retina Research Institute at New England Retina Consultants and Clinical Assistant Professor at the UMass Chan Medical School-Baystate.  He received his medical degree from Sidney Kimmel Medical College, completed residency at Wills Eye Hospital, and vitreoretinal fellowship at Tufts School of Medicine/Ophthalmic Consultants of Boston.

Dr. Lally is a leading retinal clinical researcher for innovative treatments in retinal disease, particularly for non-exudative and exudative macular degeneration.  He has served as an investigator for over 70 clinical trials and has authored over 40 peer-reviewed articles.  Dr. Lally is a scientific advisor to many programs in therapeutic clinical development serving as member of numerous clinical trial steering committees as well as scientific advisory boards.  He was a key advisor to the development of the first two FDA-approved therapies for the treatment of geographic atrophy and an author of these landmark scientific publications.

Dr. Lally received the Fellow of the American Society of Retinal Specialists (FASRS) award designation by the American Society of Retinal Specialists (ASRS), and he is an elected member of Retina Society.  In 2022, he was selected to 40 Under 40 by Ophthalmology Management recognizing “the next generation of ophthalmology: 40 ophthalmologists under 40 years old who have achieved excellence in their field.”  Dr. Lally is frequently invited as a guest speaker at national and international meetings.

Dr. Lally’s interests include geographic atrophy, macular degeneration, diabetic retinopathy, retinal vein occlusion, complex retinal detachment repair, macular hole, epiretinal membrane, and complications from cataract surgery.

To search for publications by this doctor, visit the National Library of Medicine website.